# Multi Immunotherapy to Test Tolerance and Xolair

> **NCT02626611** · PHASE2 · COMPLETED · sponsor: **Kari Christine Nadeau** · enrollment: 70 (actual)

## Conditions studied

- Food Allergy

## Interventions

- **DRUG:** Omalizumab
- **DRUG:** Food Flour Buildup

## Key facts

- **NCT ID:** NCT02626611
- **Lead sponsor:** Kari Christine Nadeau
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-11-16
- **Final completion:** 2016-11-16
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2017-12-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02626611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02626611, "Multi Immunotherapy to Test Tolerance and Xolair". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02626611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*